FDA gives full approval to a drug designed to slow Alzheimer's disease

[ad_1]
FDA gives full approval to a drug designed to slow Alzheimer's disease - CBS News

Watch CBS News

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.

[ad_2] Source link https://worldnews2023.com/health/fda-gives-full-approval-to-a-drug-designed-to-slow-alzheimers-disease/?feed_id=309338&_unique_id=668b8fdb27ad1

Comments

Popular posts from this blog

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’

Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say

Casemiro has improved Man Utd: Maguire | The Express Tribune